Main sector:
Biotechnology - Therapeutics and Diagnostics
Subsectors:
Antibodies
Anti-infectives
Cell therapy
Nucleic acid drugs
Small molecules
Vaccines
Immunotherapy
Antibody-drug-conjugate
Indications:
Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Respiratory / pulmonology
Products
In development: 63
On the market: 7
Description:
Biopharmaceutical New Technologies (BioNTech) is a global next generation immunotherapy company pioneering novel investigative therapies for cancer and other serious diseases. BioNTech exploits a wide array of computational discovery and therapeutic modalities with the intent of rapid development of novel biopharmaceuticals. Its diversified portfolio of oncology product candidates aiming to address the full continuum of cancer includes mRNA cancer immunotherapies, next-generation immunomodulators...
